ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2018

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach.

Richard F Pollock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.